Overview

Metformin in Overweight Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The study included 102 overweight type 2 diabetes mellitus patients with a body mass index (BMI) of more than 25 in an open label study. They were advised intensive life style modification which was reinforced at each follow-up visit. In addition they were prescribed extended release metformin (XR) in a gradually increasing tolerable dose, starting with 0.5g twice a day after meals. In addition, hypertension and dyslipidemia, when present, were treated with appropriate recommended drugs. Those who completed a satisfactory regular follow-up for at least 12 months or more were then analyzed for changes in their anthropometric measurements and glycemic control.
Phase:
N/A
Details
Lead Sponsor:
Era's Lucknow Medical College
Treatments:
Metformin